APA (7th ed.) Citation

JS, L., M, M., MO, B., F, T., BA, V. T., SP, D., . . . J, R. (2025). Phase 1 study of IMCnyeso, a T cell receptor bispecific ImmTAC targeting NY-ESO-1-expressing malignancies. Cell reports. Medicine, 6(4), 101994. https://doi.org/10.1016/j.xcrm.2025.101994

Chicago Style (17th ed.) Citation

JS, Lopez, et al. "Phase 1 Study of IMCnyeso, a T cell Receptor Bispecific ImmTAC Targeting NY-ESO-1-expressing Malignancies." Cell Reports. Medicine 6, no. 4 (2025): 101994. https://doi.org/10.1016/j.xcrm.2025.101994.

MLA (9th ed.) Citation

JS, Lopez, et al. "Phase 1 Study of IMCnyeso, a T cell Receptor Bispecific ImmTAC Targeting NY-ESO-1-expressing Malignancies." Cell Reports. Medicine, vol. 6, no. 4, 2025, p. 101994, https://doi.org/10.1016/j.xcrm.2025.101994.